Simplex Trading’s Enanta Pharmaceuticals ENTA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $27.8K | Buy |
2,200
+900
| +69% | +$12.1K | ﹤0.01% | 6470 |
|
|
2025
Q4 | $20.5K | Sell |
1,300
-8,500
| -87% | -$108K | ﹤0.01% | 6456 |
|
|
2025
Q3 | $117K | Buy |
9,800
+8,800
| +880% | +$70.3K | ﹤0.01% | 5556 |
|
|
2025
Q2 | $7K | Buy |
1,000
+500
| +100% | +$3.01K | ﹤0.01% | 7541 |
|
|
2025
Q1 | $2K | Buy |
+500
| New | +$3.09K | ﹤0.01% | 7973 |
|
|
2024
Q4 | – | Sell |
-100
| Closed | -$1K | – | 8778 |
|
|
2024
Q3 | $1K | Sell |
100
-2,900
| -97% | -$37.9K | ﹤0.01% | 8177 |
|
|
2024
Q2 | $38K | Sell |
3,000
-900
| -23% | -$12.1K | ﹤0.01% | 6340 |
|
|
2024
Q1 | $68K | Buy |
3,900
+2,000
| +105% | +$26.5K | ﹤0.01% | 5969 |
|
|
2023
Q4 | $17K | Buy |
+1,900
| New | +$17.7K | ﹤0.01% | 7046 |
|
|
2023
Q3 | – | Sell |
-700
| Closed | -$14K | – | 8938 |
|
|
2023
Q2 | $14K | Sell |
700
-200
| -22% | -$5.9K | ﹤0.01% | 7088 |
|
|
2023
Q1 | $36K | Buy |
900
+600
| +200% | +$28.7K | ﹤0.01% | 6285 |
|
|
2022
Q4 | $13K | Sell |
300
-2,100
| -88% | -$95.7K | ﹤0.01% | 7278 |
|
|
2022
Q3 | $124K | Buy |
2,400
+1,400
| +140% | +$81.8K | ﹤0.01% | 5232 |
|
|
2022
Q2 | $47K | Hold |
1,000
| – | – | ﹤0.01% | 6580 |
|
|
2022
Q1 | $71K | Buy |
+1,000
| New | +$65.1K | ﹤0.01% | 6633 |
|
|
2021
Q4 | – | Sell |
-1,200
| Closed | -$53K | – | 10701 |
|
|
2021
Q3 | $53K | Hold |
1,200
| – | – | ﹤0.01% | 7445 |
|
|
2021
Q2 | $52K | Buy |
1,200
+1,190
| +11,900% | +$58.3K | ﹤0.01% | 7598 |
|
|
2021
Q1 | $49K | Buy |
+10
| New | +$499 | ﹤0.01% | 6644 |
|
|
2020
Q4 | – | Sell |
-4
| Closed | -$18K | – | 8515 |
|
|
2020
Q3 | $18K | Buy |
4
+3
| +300% | +$145 | ﹤0.01% | 6425 |
|
|
2020
Q2 | $5K | Sell |
1
-9
| -90% | -$466 | ﹤0.01% | 6963 |
|
|
2020
Q1 | $51K | Buy |
10
+6
| +150% | +$320 | ﹤0.01% | 5101 |
|
|
2019
Q4 | $24K | Sell |
4
-36
| -90% | -$2.23K | ﹤0.01% | 5811 |
|
|
2019
Q3 | $240K | Buy |
40
+29
| +264% | +$2.15K | ﹤0.01% | 3375 |
|
|
2019
Q2 | $92K | Buy |
11
+7
| +175% | +$630 | ﹤0.01% | 4268 |
|
|
2019
Q1 | $38K | Sell |
4
-1
| -20% | -$90 | ﹤0.01% | 5227 |
|
|
2018
Q4 | $35K | Buy |
+5
| New | +$383 | ﹤0.01% | 4865 |
|
|
2018
Q3 | – | Sell |
-85
| Closed | -$985K | – | 7551 |
|
|
2018
Q2 | $985K | Buy |
+85
| New | +$8.48K | ﹤0.01% | 1808 |
|
|
2017
Q3 | – | Sell |
-98
| Closed | -$4K | – | 6048 |
|
|
2017
Q2 | $4K | Buy |
+98
| New | +$3.13K | ﹤0.01% | 4746 |
|
|
2016
Q2 | – | Sell |
-40
| Closed | -$2K | – | 5935 |
|
|
2016
Q1 | $2K | Hold |
40
| – | – | ﹤0.01% | 4699 |
|
|
2015
Q4 | $5K | Buy |
+40
| New | +$1.3K | ﹤0.01% | 3855 |
|
|
2015
Q3 | – | Sell |
-13
| Closed | -$2K | – | 5654 |
|
|
2015
Q2 | $2K | Hold |
13
| – | – | ﹤0.01% | 4270 |
|
|
2015
Q1 | $16K | Buy |
+13
| New | +$506 | ﹤0.01% | 2489 |
|
Other funds holding ENTA
FCM
KAM
DTC
VCM
VPM
SSC
Simplex Trading's ENTA Position: Q1 2026 in Review
Simplex Trading reduced its Enanta Pharmaceuticals (ENTA) stake by 51% in Q1 2026, selling an estimated $6.26K and leaving 455 shares worth $5.75K. The position accounts for ﹤0.01% of the portfolio, ranked #7791.
Simplex Trading first reported a position in ENTA in Q4 2014 and has held it in 26 quarters since. The position peaked at $508K in Q2 2018. 132 funds tracked by Wall St. Rank hold ENTA as of Q1 2026.
- Simplex Trading held 455 shares of Enanta Pharmaceuticals worth $5.75K as of Q1 2026.
- Simplex Trading sold 467 Enanta Pharmaceuticals shares in Q1 2026, an estimated $6.26K.
- Enanta Pharmaceuticals made up ﹤0.01% of Simplex Trading's portfolio in Q1 2026, its #7791 holding.
- Simplex Trading first reported a position in Enanta Pharmaceuticals in Q4 2014 and has held it in 26 quarters since.
- Simplex Trading's Enanta Pharmaceuticals position peaked at $508K in Q2 2018.
- 132 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q1 2026.
Based on Simplex Trading's 13F filing for Q1 2026, filed 14 May 2026.